|
1
|
Spiro RH, Huvos AG and Strong EW: Adenoid
cystic carcinoma of salivary origin. A clinicopathologic study of
242 cases. Am J Surg. 128:512–520. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ciccolallo L, Licitra L, Cantú G and Gatta
G; EUROCARE Working Group, : Survival from salivary glands adenoid
cystic carcinoma in European populations. Oral Oncol. 45:669–674.
2009. View Article : Google Scholar
|
|
3
|
Bjørndal K, Krogdahl A, Therkildsen MH,
Overgaard J, Johansen J, Kristensen CA, Homøe P, Sørensen CH,
Andersen E, Bundgaard T, et al: Salivary gland carcinoma in Denmark
1990–2005: A national study of incidence, site and histology.
Results of the Danish head and neck cancer group (DAHANCA). Oral
Oncol. 47:677–682. 2011. View Article : Google Scholar
|
|
4
|
Atallah S, Casiraghi O, Fakhry N, Wassef
M, Uro-Coste E, Espitalier F, Sudaka A, Kaminsky MC, Dakpe S, Digue
L, et al: A prospective multicentre REFCOR study of 470 cases of
head and neck adenoid cystic carcinoma: Epidemiology and prognostic
factors. Eur J Cancer. 130:241–249. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coca-Pelaz A, Rodrigo JP, Bradley PJ,
Vander Poorten V, Triantafyllou A, Hunt JL, Strojan P, Rinaldo A,
Haigentz M Jr, Takes RP, et al: Adenoid cystic carcinoma of the
head and neck-An update. Oral Oncol. 51:652–661. 2015. View Article : Google Scholar
|
|
6
|
Ouyang DQ, Liang LZ, Zheng GS, Ke ZF, Weng
DS, Yang WF, Su YX and Liao GQ: Risk factors and prognosis for
salivary gland adenoid cystic carcinoma in southern China: A
25-year retrospective study. Medicine (Baltimore). 96:e59642017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nightingale J, Lum B, Ladwa R, Simpson F
and Panizza B: Adenoid cystic carcinoma: A review of clinical
features, treatment targets and advances in improving the immune
response to monoclonal antibody therapy. Biochim Biophys Acta Rev
Cancer. 1875:1885232021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Weert S, Bloemena E, van der Waal I,
de Bree R, Rietveld DH, Kuik JD and Leemans CR: Adenoid cystic
carcinoma of the head and neck: A single-center analysis of 105
consecutive cases over a 30-year period. Oral Oncol. 49:824–829.
2013. View Article : Google Scholar
|
|
9
|
Dalal P, Dermody S, Brummel C, Brenner C,
Casper K, Chinn SB, Malloy KM, Mierzwa ML, Neal MH, Prince MEP, et
al: Clinical outcomes in salivary adenoid cystic carcinoma. J Clin
Oncol. 42 (Suppl 16):S6102. 2024. View Article : Google Scholar
|
|
10
|
Gao M, Hao Y, Huang MX, Ma DQ, Luo HY, Gao
Y, Peng X and Yu GY: Clinicopathological study of distant
metastases of salivary adenoid cystic carcinoma. Int J Oral
Maxillofac Surg. 42:923–928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jang S, Patel PN, Kimple RJ and McCulloch
TM: Clinical outcomes and prognostic factors of adenoid cystic
carcinoma of the head and neck. Anticancer Res. 37:3045–3052.
2017.PubMed/NCBI
|
|
12
|
Fang Y, Peng Z, Wang Y, Gao K, Liu Y, Fan
R, Zhang H, Xie Z and Jiang W: Current opinions on diagnosis and
treatment of adenoid cystic carcinoma. Oral Oncol. 130:1059452022.
View Article : Google Scholar
|
|
13
|
Walker M, Dewald A, Refaey A, Berezowski
I, Newman J, Younes M and Gray S: Salivary gland adenoid cystic
carcinoma presenting as a large metastatic hepatic mass: A case
report. J Med Case Rep. 19:1262025. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brincat SD and Cassar N: Solitary liver
metastasis from adenoid cystic carcinoma of the submandibular
gland. BMJ Case Rep. 17:e2589232024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li XH, Zhang YT and Feng H: Liver
metastasis as the initial clinical manifestation of sublingual
gland adenoid cystic carcinoma: A case report. World J Clin Cases.
9:5238–5244. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Spolverato G, Fite J, Bishop J, Argani P
and Pawlik TM: Liver metastasis as the initial presentation of
adenoid cystic carcinoma. Dig Dis Sci. 59:2004–2006. 2014.
View Article : Google Scholar
|
|
17
|
Garg N, Tomar R, Goyal S and Singh UR:
Isolated liver metastases in an adenoid cystic carcinoma of the
submandibular gland on fine needle aspiration cytology: An unusual
presentation. Cytopathology. 25:137–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karatzas A, Katsanos K, Maroulis I,
Kalogeropoulou C, Tzorakoleftherakis E and Karnabatidis D:
Multi-modality curative treatment of salivary gland cancer liver
metastases with drug-eluting bead chemoembolization, radiofrequency
ablation, and surgical resection: A case report. J Med Case Rep.
5:4162011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deshpande AH and Kelkar AA: Hepatic
metastasis as an initial manifestation of salivary adenoid cystic
carcinoma: Cytologic diagnosis. Diagn Cytopathol. 37:45–47. 2009.
View Article : Google Scholar
|
|
20
|
Zhou M, Ma T, Wang X, Zhang S, Yang G,
Song R and Chen X: High-risk subtype: Clinical manifestations and
molecular characteristics of submandibular gland adenoid cystic
carcinoma. Front Oncol. 12:10211692022. View Article : Google Scholar
|
|
21
|
Megwalu UC and Sirjani D: Risk of nodal
metastasis in major salivary gland adenoid cystic carcinoma.
Otolaryngol Head Neck Surg. 156:660–664. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tasoulas J, Divaris K, Theocharis S,
Farquhar D, Shen C, Hackman T and Amelio AL: Impact of tumor site
and adjuvant radiotherapy on survival of patients with adenoid
cystic carcinoma: A SEER database analysis. Cancers (Basel).
13:5892021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mishra R, Patel H, Alanazi S, Kilroy MK
and Garrett JT: PI3K inhibitors in cancer: Clinical implications
and adverse effects. Int J Mol Sci. 22:34642021. View Article : Google Scholar
|
|
24
|
Ren Y, Hong Y, He W, Liu Y, Chen W, Wen S
and Sun M: EGF/EGFR promotes salivary adenoid cystic carcinoma cell
malignant neural invasion via activation of PI3K/AKT and MEK/ERK
signaling. Curr Cancer Drug Targets. 22:603–616. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Zhang Y, Zhang Y and Li B: A
bibliometric analysis of gastric cancer liver metastases: Advances
in mechanisms of occurrence and treatment options. Int J Surg.
110:2288–2299. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Geiger JL, Ismaila N, Beadle B, Caudell
JJ, Chau N, Deschler D, Glastonbury C, Kaufman M, Lamarre E, Lau
HY, et al: Management of salivary gland malignancy: ASCO guideline.
J Clin Oncol. 39:1909–1941. 2021. View Article : Google Scholar
|
|
27
|
Locati LD, Bossi P, Perrone F, Potepan P,
Crippa F, Mariani L, Casieri P, Orsenigo M, Losa M, Bergamini C, et
al: Cetuximab in recurrent and/or metastatic salivary gland
carcinomas: A phase II study. Oral Oncol. 45:574–578. 2009.
View Article : Google Scholar
|
|
28
|
Agulnik M, Cohen EWE, Cohen RB, Chen EX,
Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, et
al: Phase II study of lapatinib in recurrent or metastatic
epidermal growth factor receptor and/or erbB2 expressing adenoid
cystic carcinoma and non-adenoid cystic carcinoma malignant tumors
of the salivary glands. J Clin Oncol. 25:3978–3984. 2007.
View Article : Google Scholar
|
|
29
|
Guigay J, Fayette J, Even C, Cupissol D,
Rolland F, Peyrade F, Laguerre B, Le Tourneau C, Zanetta S, Le Moal
LB, et al: PACSA: Phase II study of pazopanib in patients with
progressive recurrent or metastatic (R/M) salivary gland carcinoma
(SGC). J Clin Oncol. 34 (Suppl 15):S60862016. View Article : Google Scholar
|
|
30
|
Cheung LWT, Yu S, Zhang D, Li J, Ng PK,
Panupinthu N, Mitra S, Ju Z, Yu Q, Liang H, et al: Naturally
occurring neomorphic PIK3R1 mutations activate the MAPK pathway,
dictating therapeutic response to MAPK pathway inhibitors. Cancer
Cell. 26:479–494. 2014. View Article : Google Scholar
|
